Case Study.

Regulatory strategy for 510(k) approval and successful US market entry

An international medtech manufacturer faced the complex challenge of obtaining FDA 510(k) clearance. Successful market entry was time-critical and strategically important for product positioning.

The Challenge.

A targeted market entry in the USA was crucial.

  • A fixed timeframe jeopardized the timely product launch.
  • Lack of experience with FDA requirements led to uncertainties.
  • Open CE documentation delayed the process.
  • Unclear clinical evidence made marketing claims difficult.

The Benefits.

  • Classification of the product to confirm the 510(k) approval pathway
  • Controlling the integration of EU documentation through a gap analysis
  • Coordination with the FDA to clarify marketing claims through the Q-Sub process
  • Project management: Scheduling and resource alignment for 510(k) approach

The Outcome.

Schedule predictability increased

All deadlines were met thanks to precise planning and control.

Smooth market entry

510(k) clearance was obtained on schedule through careful coordination for product exhibition at the convention.

Efficiency increase achieved

Backward planning and optimal use of resources ensured on-time and on-budget submission.

The Result.

The strategic market entry in the USA was achieved on schedule, which significantly strengthened the market position.